Defendants. )
Transcript of Defendants. )
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF TENNESSEE
UNITED STATES OF AMERICA, ) )
���� ) )
Civil Action No. -----
V. ) )
KEYSTONE LABORATORIES, INC., a corporation,)
CONSENT DECREE OF PERMANENT INJUNCTION
MELINDA MENKE and ELIZABETH JUMET, ) individuals, )
) Defendants. )
_________________ )
Plaintiff, the United States of America, by and through its undersigned attorneys, having
filed a Complaint for Permanent Injunction against Keystone Laboratories, Inc., a corporation,
and Melinda Menke and Elizabeth Jumet, individuals (hereinafter, collectively, "Defendants"),
and Defendants having appeared and consented to entry of this Decree without contest, and
before any testimony has been taken, and the United States of America, having consented to this
Decree;
IT IS HEREBY ORDERED, ADJUDGED, AND DECREED as follows:
1. This Court has jurisdiction over the subject matter of this action and all parties to this
action. Venue is proper in this District under 28 U.S.C. § 1391(b) and (c).
2. The Complaint states a cause of action against Defendants under the Federal
Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301 et seq. (the "Act").
3. The Complaint alleges that Defendants violate 21 U.S.C. § 33 l(a) by introducing or
delivering for introduction, or causing to be introduced or delivered for introduction, into
interstate commerce articles of drug, as defined by 21 U.S.C. § 321(g)(l), that are adulterated
18-2656
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 1 of 26 PageID 20
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 2 of 26 PageID 21
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 3 of 26 PageID 22
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 4 of 26 PageID 23
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 5 of 26 PageID 24
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 6 of 26 PageID 25
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 7 of 26 PageID 26
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 8 of 26 PageID 27
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 9 of 26 PageID 28
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 10 of 26 PageID 29
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 11 of 26 PageID 30
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 12 of 26 PageID 31
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 13 of 26 PageID 32
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 14 of 26 PageID 33
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 15 of 26 PageID 34
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 16 of 26 PageID 35
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 17 of 26 PageID 36
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 18 of 26 PageID 37
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 19 of 26 PageID 38
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 20 of 26 PageID 39
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 21 of 26 PageID 40
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 22 of 26 PageID 41
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 23 of 26 PageID 42
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 24 of 26 PageID 43
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 25 of 26 PageID 44
Case 2:18-cv-02656-JTF-dkv Document 1-2 Filed 09/25/18 Page 26 of 26 PageID 45